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Introduction: Nurses and other non-specialists in dysphagia are often trained to screen swallowing 6 
post-stroke. There are many basic tools that test water only, they are usually conservative and 7 
patients that fail the test remain nil by mouth until a speech and language therapy assessment. 8 
More comprehensive tests also allow non-specialists to recommend modified oral intake. Little is 9 
known about the accuracy, clinical utility and cost effectiveness of these tests.  10 
Methods:  Following PRISMA guidelines, a systematic review was conducted to describe 11 
comprehensive swallowing tests that are available for use in acute stroke by nurses or other non-12 
specialists in dysphagia. A meta-analysis was performed to evaluate accuracy and considered their 13 
clinical utility. Searches and analyses, conducted by two reviewers, included MEDLINE, EMBASE, trial 14 
registries, and grey literature up to December 2018. Validated studies were assessed for quality and 15 
risk of bias using QUADAS-2. 16 
Results:  Twenty studies were included, describing five different tests, three of which had undergone 17 
validation. The tests varied in content, recommendations and use. There was no test superior in 18 
accuracy and clinical utility.  Three studies validating the Gugging Swallow Screen provided sufficient 19 
data for meta-analysis, demonstrating high sensitivity; 96% (95%CI 0.90-0.99) but low specificity, 20 
65% (95%CI 0.47-0.79) in line with many water swallow tests. Results should be interpreted with 21 
caution as study quality and applicability to the acute stroke population was poor. 22 
Conclusions: There is no comprehensive nurse dysphagia assessment tool that has robustly 23 
demonstrated good accuracy, clinical utility and cost effectiveness in acute stroke. 24 
Relevance to Clinical Practice:  Nurses and other clinicians can develop competencies in screening 25 
swallowing and assessing for safe oral intake in those with post stroke dysphagia. It is important to 26 
use a validated assessment tool that demonstrates good accuracy, clinical utility and cost 27 
effectiveness.  28 
What does this paper contribute to the wider global clinical community?  29 
 A description of how nurses and other clinicians are involved in screening and assessment of 30 
swallowing after acute stroke 31 
 2 
 A summary and critique of the available tools for nurses and other clinicians to screen and 1 
assess swallowing within the acute stroke pathway  2 
 An idea of how nurse-based screening and assessment of swallow post acute stroke might 3 
impact on patient outcomes  4 
 5 
Key words: swallowing, dysphagia, assessment, screening, stroke, multidisciplinary, nurse 6 
  7 
Introduction 8 
Post stroke dysphagia is common, affecting around 50% of acute stroke patients (Martino et al., 2005).  9 
Early identification is key to reduce rates of stroke associated pneumonia and mortality (Bray et al., 10 
2016; Yeh et al., 2011). Speech and Language Therapists (SLT) are, in many countries, considered to 11 
be the specialists in assessment and management of dysphagia.  However, swallow screening tools 12 
such as water swallow tests are often used by non-specialists in dysphagia, including nurses, to identify 13 
patients at risk of aspiration and refer patients for further assessment by SLT. There are a multitude 14 
of screening tools described in the literature and systematic reviews have demonstrated that some of 15 
the best tools have good sensitivity but often lower specificity (Schepp, Tirschwell, Miller, & 16 
Longstreth, 2012).  This translates to many patients unnecessarily remaining nil by mouth (NBM) for 17 
prolonged periods, with or without nasogastric tube feeding, until they are assessed by a SLT, which 18 
can have negative consequences (Langdon, Lee, & Binns, 2007; Langmore, Krisciunas, Miloro, Evans, 19 
& Cheng, 2012). Water swallow tests have been criticised because swallowing water is not the same 20 
as swallowing food (Marques, De Rosso, & Andre, 2008) and the tools have often been validated for 21 
screening aspiration, one of the possible consequences of dysphagia, rather than for the presence of 22 
dysphagia itself (Sasaki & Leder, 2014). Reduced efficiency or uncontrolled oral and pharyngeal transit 23 
and clearance, impaired mastication and reduced sensation may result in other symptoms such as 24 
choking and sub-optimal nutrition (Serra-Prat et al., 2012; Smithard et al., 1996). Aside from water 25 
swallow tests, there are several more comprehensive swallowing tests that mean non-specialists can 26 
screen for dysphagia and also assess various diet and fluid consistencies, so safe oral intake may be 27 
commenced earlier.  To date there has been no review identifying, describing or comparing these 28 
more comprehensive tests. 29 
It is essential that dysphagia screening tools have adequate accuracy and are safe to use clinically. The 30 
UK National Institute of Health and Care Excellence (NICE) 2016 Stroke Guidelines say that swallowing 31 
should be assessed using a validated tool (Royal College of Physicians Intercollegiate Stroke Working 32 
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Party, 2016). There is also a move to demonstrate the clinical utility of screening and diagnostic tests, 1 
not only the technical performance in accurately screening for and diagnosing a condition (Bossuyt, 2 
Reitsma, Linnet, & Moons, 2012; Thompson, Plüddemann, Price, & Heneghan, 2013). In the case of 3 
patients with dysphagia, clinical utility refers to how the tests improve the clinical outcomes of the 4 
patients such as pneumonia rates and be more cost effective than other tools or pathways.  5 
Aims 6 
A systematic review was conducted to describe the comprehensive tools that are available for nurses 7 
or other members of the multidisciplinary team (MDT) to screen swallowing and assess for safe oral 8 
intake post stroke. The clinical utility of the tests is described, the results of a meta-analysis are 9 
presented and the quality of the tools that had undergone validation is discussed.  10 
Methods 11 
A systematic review of the English and Spanish literature was completed by searching databases; 12 
MEDLINE, EMBASE, CINAHL, Web of Science, Trial databases; Clinicaltrials.gov, ICTRP and grey 13 
literature from start to October 2018.  See Appendix 1 for an example of the search criteria used in 14 
EMBASE. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (Moher, Liberati, 15 
Tetzlaff, & Altman, 2009) guidance was followed (see completed checklist in Supplementary File 1). 16 
Identified studies at different stages of the process were managed in folders on EndNote. 17 
Inclusion criteria 18 
Inclusion criteria for the narrative review was broad as the number of published tools was estimated 19 
to be small.  Studies were included in the narrative review if they had sufficient information in 20 
English or Spanish to establish that they described a comprehensive nursing or MDT assessment of 21 
swallowing to screen for dysphagia in stroke patients. Comprehensive assessment was defined as a 22 
screening test for dysphagia that included assessing more than one diet or fluid texture allowing for 23 
recommendations of modified diet and fluids where appropriate.  For the quantitative analysis, 24 
studies were included if they gave data regarding the accuracy of the assessment tool such as 25 
sensitivity and specificity.  Studies were also included that reported the cost effectiveness or clinical 26 
utility of a test.  27 
Study selection  28 
One reviewer (JB) searched the titles and abstracts and excluded non-relevant studies. Full text was 29 
requested for relevant studies that could be included in a narrative review and, in the case of 30 
validation studies, a quantitative review.  Data extraction and assessment of quality were carried out 31 
by the same reviewer (JB). Decisions for inclusion and exclusion, based on eligibility criteria were 32 
discussed and agreed with a second reviewer (LE). The second reviewer (LE) also reviewed and 33 
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agreed the data extraction and quality assessments. Any disagreements were discussed with a third 1 
reviewer (TE).  2 
Data extraction 3 
Data were extracted using a predesigned form (Appendix 2) including information on the content of 4 
the tests, possible outcomes, who administers the test and what training they require. For validation 5 
papers data were collected using the Revised Quality Assessment of Diagnostic Accuracy Studies 6 
(QUADAS-2) (Whiting, Rutjes, Westwood, & et al., 2011) on the gold standard reference test used, 7 
the time between assessments, whether blinding occurred for example (Appendix 3). Authors were 8 
contacted where details were unclear or data were not present.  9 
Risk of Bias 10 
Risk of bias and applicability of primary diagnostic accuracy studies were assessed using the four 11 
domains of the QUADAS-2 (Whiting et al., 2011). 1. Patient selection; were patients recruited 12 
consecutively? Were they representative of an acute stroke setting?  2. Index test; who carried out 13 
the index test (the test being validated)? Were they blinded to other tests? 3. Reference standard; 14 
was the gold standard an acceptable assessment to compare to? Were the assessors blinded to the 15 
results of the index text? 4. Flow and timing; what was the time between the index and reference 16 
test? Was all data (including missing data) reported?  Prior to the quality assessment it was decided 17 
that to be classed as low concern for applicability to an acute stroke population, over 50% of 18 
participants in the sample needed to be representative of acute stroke patients; defined as newly 19 
admitted (less than one week post stroke), including all types and severities of stroke and who may 20 
or may not have dysphagia.  Overall quality was summarised using the GRADE guidelines 21 
(Schunemann et al., 2008). 22 
Statistical Analysis  23 
Diagnostic accuracy data for the studies validating an assessment tool were summarised. Sensitivity, 24 
specificity, positive and negative predictive values, receiver operating characteristic curve, inter and 25 
intra rater reliability were included where available as were the respective confidence intervals 26 
which gives an indication of consistency. Studies that reported a 2x2 table detailing numbers of true 27 
and false positives and negatives were included in a meta-analysis(Macaskill P, 2010). The data were 28 
analysed in STATA using a hierarchical model (HSROC) accounting for both within- and between 29 
study heterogeneity (Lee, Kim, Choi, Huh, & Park, 2015; Macaskill P, 2010; Takwoingi, April 2016). 30 
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Results 1 
Database searches identified 868 studies and grey literature searches found a further 48 studies. See 2 
PRISMA flow diagram (Fig. 1). After duplicates were removed and titles and abstracts were screened, 3 
60 full texts were requested and reviewed.  After exclusions, 20 met the criteria for the narrative 4 
review.  5 
Identified tests 6 
Five tests were identified and are summarised in Table 1. They are described as tests, screening tools 7 
and assessments. They all met the criteria as a screening tool for dysphagia and included testing 8 
different consistencies so that those who fail with water but can safely manage some oral intake can 9 
be recommended modified diet and fluids whilst they wait for further assessment by SLT. The 10 
Gugging Swallow Screening (GUSS, n=11 publications) and Volume Viscosity Swallowing Test (VVST, 11 
n=4) advise the use of instrumental assessments if dysphagia is identified on the test (Clave et al., 12 
2008; Trapl et al., 2007).  The VVST and the Dysphagia Trained Nurse Assessment (DTNAx, n=3 13 
publications) suggest they can also be used to review patient’s swallowing (Guillen-Sola et al., 2013; 14 
Mary Heritage, 2003).   15 
Non-swallow section 16 
The GUSS, Bedside Swallow Screening Test (BESST, n=1) and DTNAx include a non-swallow section at 17 
the beginning before offering any oral trials (Benfield, 2018; E. Boaden, 2011; Trapl et al., 2007). This 18 
varies from observation of respiration, swallowing and alertness levels to direct testing of oromotor 19 
function. If this section is failed in the GUSS and the BESST then the rest of the assessment is not 20 
administered and the patient remains NBM. In the DTNAx, whether the non-swallow section was 21 
passed or failed the assessment proceeds to swallow trials.   The VVST and Two Volume Three 22 
Texture Test (2v/3t-P, n=1) do not include a non-swallow section and the papers are not clear about 23 
whether there are any patients who are not suitable to be tested (Cocho et al., 2017; Rofes, Arreola, 24 
Mukherjee, & Clave, 2014).   25 
Oral trials 26 
Many countries have not adopted the International Dysphagia Descriptors Standardisation Initiative 27 
(IDDSI) framework (The International Dysphagia Diet Standardisation Initiative, 2016 ) and many of 28 
these tests were devised before IDDSI was launched in 2015. The DTNAx and the GUSS have been 29 
converted to the IDDSI framework (M. Heritage, 2001; Trapl et al., 2007). The oral trials will be 30 
described within in the IDDSI framework, levels (L) 1 to 7, where possible. 31 
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The tests vary in what is given orally. BESST evaluates two consistencies only, thin fluids (L0) and 1 
puree diet (L4). Whereas the GUSS trials thin fluids (L0), regular diet (L7) and a ‘semi-solid’ texture 2 
(L3). The 2v/3t-P tests different volumes (5 & 10mls) of thin fluids (L0), ‘semisolid’ (estimated L3 or 3 
L4) textures and regular diet (L7). The VVST tests different volumes (5, 10, 20mls) of thin fluids (L0), 4 
puree diet (L4) and nectar fluids (could be approximated to L2 fluids). The DTNAx is more 5 
comprehensive and tests a range of fluid volumes (5, 10, 100mls) and viscosities (L0, L2, and L3) and 6 
food textures (L4, L5, L6, L7). Several of the tests (Clave et al., 2008; Cocho et al., 2017; Trapl et al., 7 
2007) comment on the order of the oral trials and argue that starting with thin fluids may result in 8 
aspiration and therefore they begin with puree diet (L4) or thickened fluids.  9 
Justification for the inclusion of different textures was a theme that emerged from the literature. 10 
Umay et al 2018 points out that water is not the only thing that patients’ swallow thereby only 11 
testing water may result in false positives (Umay et al., 2018). Boaden 2011 argues that a sufficient 12 
quantity of thin fluids needs to be included in the test because small amounts of water are not 13 
representative of normal swallowing (E. Boaden, 2011). Ferreira et al 2018 suggests that assessing 14 
different consistencies is more representative of normal eating habits (Ferreira et al., 2018). St John 15 
et al 2015 et al describe how the GUSS has replaced a water swallow test in one stroke centre 16 
because the team were concerned about the safety of starting patients on diet after just being 17 
tested with water (John & Berger, 2015).  18 
Criteria for detecting aspiration or dysphagia 19 
Most of the tests use clinical judgements to determine presence of aspiration or dysphagia. In 20 
particular, all tests use presence of cough and voice changes and most use lack of laryngeal elevation 21 
(E. Boaden, 2011; Cocho et al., 2017; M. Heritage, 2001; Trapl et al., 2007). In addition, the VVST and 22 
2v/3t-P use a drop in oxygen saturations of >2% to detect silent aspiration. Other criteria varied 23 
between tests, see Table 2 for details of the full criteria each test uses to determine aspiration or 24 
dysphagia.  25 
Outcomes  26 
A common theme was highlighted in the literature; non-expert professionals can use the tests to 27 
commence patients on safe oral intake who would otherwise remain NBM from failing a water 28 
swallow test (E. Boaden, 2011; Cocho et al., 2017; Guillen-Sola et al., 2013; Mary Heritage, 2003; 29 
John & Berger, 2015; Trapl et al., 2007).  30 
The outcome of the tests can be: 1. Pass - where normal diet and fluids are recommended, 2. Fail – 31 
where the patient is recommended to remain NBM or 3. Fail - with recommendations of a modified 32 
diet and fluids.  The more comprehensive the test the wider the range of modified diet and fluids 33 
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recommendations.  The BESST only recommends puree/pudding (L4) consistency as the modified 1 
option. The VVST and 2v/3t-P can recommend different volumes of thin fluids (L0), thickened fluid 2 
and pureed diet (L4).  The DTNAx can recommend several different thickened fluids and a range of 3 
modified diets. Several tests recommend textures that have not been directly tested; the BESST and 4 
VVST allow recommendations of normal diet (L7) when only puree texture is assessed and the GUSS 5 
recommends ‘soft food’ and different levels of thickened fluids when only thin (L0), puree/pudding 6 
(L4) and normal diet (L7) are tested.  7 
None of the studies validating the tools collected outcomes of the patients following the initial index 8 
and reference tests.  9 
Administration time 10 
The GUSS, VVST, BESST are reported to take between 5-10 minutes to administer, the DTNAx takes 11 
around 20 minutes and there is no information on the 2v/3t-P test.  12 
Pathway 13 
Three of the tests (E. Boaden, 2011; Cocho et al., 2017; M. Heritage, 2001) have been designed and, 14 
in some cases (E. Boaden, 2011), validated to be the initial swallow test an acute stroke patient 15 
receives before commencing oral intake. The other two (Rofes et al., 2014; Trapl et al., 2007) are 16 
intended to be used after an initial screening to identify those at risk of dysphagia who need a more 17 
detailed test.  18 
Profession, training and competence 19 
The tests are designed to be carried out by non-specialists in dysphagia, in most cases nurses (E. 20 
Boaden, 2011; Cocho et al., 2017; Mary Heritage, 2003; Trapl et al., 2007) but also physicians and 21 
dietitians (Rofes et al., 2014). The GUSS and the VVST papers suggest it can also be used by SLTs as a 22 
standardised bedside assessment (Ferreira et al., 2018; Rofes et al., 2014). 23 
Little is known about the training required in order to be able to administer the tests, from what has 24 
been documented the training received is very variable. The BESST requires no training. The GUSS 25 
required a short theory session and an observation of the test being administered. The VVST and 26 
DTNAx require theory and practical sessions using the test. The DTNAx includes an assessment of 27 
competency in administering the test by an SLT.  28 
Accuracy 29 
Three of the identified tools (E. Boaden, 2011; Clave et al., 2008; Trapl et al., 2007) have undergone 30 
validity and reliability testing (Table 3) and the DTNAx is currently being validated – (Clinical 31 
trials.gov NCT03700853). The GUSS and the VVST used an instrumental assessment (FEES or VFS) as 32 
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the gold standard to validate the tests, the BESST was validated against an experienced SLT 1 
performing a clinical bedside assessment. All tests demonstrated good sensitivity (87.5% - 100%) and 2 
variable specificity (28% - 96.1%).  The lower levels of specificity came from the VVST for identifying 3 
aspiration (Clave et al., 2008; Guillen-Sola et al., 2013; Rofes et al., 2014) but sensitivity (94%, 95% 4 
confidence interval, CI, 0.87–0.98) and specificity (88%, 95% CI, 0.50–0.99) for identifying dysphagia 5 
was higher (Rofes et al., 2014).  6 
Only three of the studies (AbdelHamid & Abo-Hasseba, 2017; Trapl et al., 2007; Warnecke et al., 7 
2017), all validating GUSS, reported detailed data that could be included in a meta-analysis. Figure 2 8 
compares validation data across these studies; overall, GUSS sensitivity and specificity was 0.96 (CI 9 
95% 0.90 - 0.99) and 0.65 (CI 95% 0.47 - 0.79) respectively. The summary receiving operator curve 10 
(SROC) could not be estimated due to there being less than 4 studies.  11 
Quality 12 
Most studies demonstrated very low (AbdelHamid & Abo-Hasseba, 2017; Clave et al., 2008; Ferreira 13 
et al., 2018; Guillen-Sola et al., 2013; Rofes et al., 2014; Samia E S B, 2017; Umay et al., 2018; 14 
Warnecke et al., 2017) or low quality (Trapl et al., 2007) according to the QUADAS-2 (Whiting et al., 15 
2011) and GRADE criteria (Schunemann et al., 2008). Table 4 shows the risk of bias and concern for 16 
applicability of each test along with the level of quality.  Reduced quality was due to concern or 17 
uncertainty regarding risk of bias or applicability of index test, reference test, patient selection 18 
methods or flow and timing. The study validating BESST (E. Boaden, 2011) demonstrated good study 19 
design, accuracy and reliability but was scored as moderate quality due to lack of a gold standard 20 
reference test and imprecise results with wide confidence intervals..   21 
Clinical utility and cost effectiveness 22 
We did not find any studies evaluating the cost effectiveness of these tools over other tools or 23 
pathways.  However, several studies evaluated the effect of using these more comprehensive tests 24 
on the clinical outcomes of patients.  25 
In a retrospective study (N=384) (Palli et al., 2017), the GUSS test was introduced into a stroke 26 
service during out of hours periods where no SLTs were available to assess and manage swallowing. 27 
This resulted in significantly reduced pneumonia rates from 11.6% before the introduction to 3.8% 28 
after (p=0.004). Median length of hospital stay also decreased from 9 days to 8 days (p=0.033). 29 
However, in another retrospective database study (N=1394) (Teuschl et al., 2018) there were no 30 
differences in pneumonia rates between patients admitted with a stroke and assessed with GUSS 31 
(5.0%) and those not assessed (5.5%). Due its methodological design, groups were not matched 32 
therefore limited conclusions can be drawn. The 2v/3t-P test also resulted in a significant reduction 33 
 9 
in pneumonia rates (6.2% before vs. 2.1% after, p = 0.05) in a prospective analysis of consecutively 1 
admitted patients (N=418) to the stroke unit when it replaced a water swallow test (Cocho et al., 2 
2017). A published clinical audit (N=61) described how acute patients were seen quicker and the 3 
number of days they spent NBM dropped by over 30% following a fivefold increase in the number of 4 
nurses trained to perform the DTNAx (M. Heritage, 2001). 5 
Discussion 6 
Nurses and other non-specialists in dysphagia assess swallowing and recommend diet and fluid 7 
intake in post stroke patients. Little is known about the content, accuracy or the way these 8 
assessments are carried out. It is important that the tools used during these assessments have 9 
undergone validation to ensure they are accurate in identifying dysphagia and that patients are 10 
being recommended safe oral intake to prevent complications such as aspiration pneumonia, 11 
choking or undernourishment.  12 
We conducted a systematic review to identify and describe the available tools and compare their 13 
accuracy and clinical utility where this had been tested.  Five different tests were identified from the 14 
literature.   The tests differed in content, the recommendations generated, the professionals 15 
administering the test and the training and competency requirements. Only three of the tests have 16 
been validated against a gold standard swallowing assessment. There was no single test that was 17 
highly accurate, backed up with a high-quality study design and that demonstrated clinical utility.  18 
The GUSS has undergone the most validation testing of all the tests and was the only test in the 19 
studies identified that was eligible for the meta-analysis. Over all it demonstrated good sensitivity 20 
(96%) and lower specificity (65%).  These pooled results represent the overall ability of the GUSS to 21 
identify risk of aspiration rather than dysphagia as not all of the studies validated the test for 22 
identification of dysphagia (AbdelHamid & Abo-Hasseba, 2017; Trapl et al., 2007).  It is possible 23 
therefore that some of the patients who pass the test in fact have dysphagia and are at risk of 24 
choking or undernutrition. The VVST had the highest accuracy for identification of dysphagia (Rofes 25 
et al., 2014).  26 
The accuracy results for the meta-analysis must be interpreted cautiously due to the limited number 27 
of studies and the mostly poor or very poor quality or applicability. Two of the studies selected 28 
patients who were already suspected as having dysphagia (AbdelHamid & Abo-Hasseba, 2017; Trapl 29 
et al., 2007) and one excluded mild strokes (Warnecke et al., 2017) therefore they did not represent 30 
the broad range of the acute stroke population in whom the test may be used. In two of the studies 31 
(AbdelHamid & Abo-Hasseba, 2017; Warnecke et al., 2017) the GUSS was performed by experts 32 
rather than non-specialists which is not applicable to the clinical use of the test. In one of the 33 
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studies(AbdelHamid & Abo-Hasseba, 2017) the timing was unclear between the GUSS and the 1 
reference test (FEES) and there was no reporting of any missing data. Individually and to some 2 
extent in the pooled data the studies demonstrated imprecise results with wide confidence intervals 3 
especially with specificity.  The issues with quality could have skewed the results; for example, the 4 
high sensitivity may in part be due to the test only being carried out on participants already 5 
identified as being at risk of dysphagia (AbdelHamid & Abo-Hasseba, 2017; Trapl et al., 2007) or with 6 
more severe strokes (Warnecke et al., 2017).  The strict non-swallow section which results in a test 7 
failure for those with reduced oromotor function and places the patient NBM until further 8 
assessment might explain the low specificity (Warnecke et al., 2017; Wirth et al., 2013). This 9 
specificity is comparable to some of the best water swallow tests (Schepp, Tirschwell, Miller, & 10 
Longstreth Jr, 2012).  From a clinical utility perspective the GUSS may be better than no test (Palli et 11 
al., 2017) but not better than a water swallow test (Teuschl et al., 2018) at reducing pneumonia 12 
rates. There is also a jump between the diet and fluid consistencies tested to those recommended; 13 
for example, a patient can be recommended IDDSI L1 or L2 fluids and L5 diet without having been 14 
tested with any of these. In the same way, water swallow tests are also criticised for allowing normal 15 
diet intake without assessment (Marques et al., 2008). Given it may not be any more accurate, safe 16 
or clinically effective than water swallow tests, and training and administration time is greater, the 17 
GUSS may be less cost effective. 18 
The BESST was of moderate quality and had acceptable sensitivity and negative predictive value with 19 
lower specificity to identifying dysphagia. However, the reference test used was a clinical bedside 20 
assessment (CBA) which could be argued is not a gold standard assessment of swallowing, especially 21 
because a validated CBA was not used.  CBA have been shown to be less effective at describing 22 
dysphagia and identifying aspiration (Splaingard, Hutchins, Sulton, & Chaudhuri, 1988) than gold 23 
standard instrumental assessments and the author acknowledges this as a limitation with the BESST 24 
validation.  25 
The construct validity of the tests has not been reported. This pertains to how well a test is 26 
constructed to identify dysphagia based on what is known about dysphagia. There are some 27 
common characteristics across the tests that suggests good construct validity: all of the tests 28 
evaluate liquids and solids; and they all have criteria for judging both the oral stage and pharyngeal 29 
stages of swallowing. This includes specifics on identifying signs of aspiration such as cough and 30 
voice change which have been shown to be the most reliable signs in water swallow tests (Brodsky 31 
et al., 2016). Progressive volumes of thin fluids also increases accuracy of identifying aspiration 32 
(Brodsky et al., 2016), most of the tests do this to some degree. However, there are limitations in 33 
some of the tests that reduce their construct validity.  Two of the tests to do not include food 34 
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textures that are part of regular diet (E. Boaden, 2011; Clave et al., 2008). Also, it has been 1 
established that bedside assessments are limited in detecting silent aspiration(McCullough et al., 2 
2005). Two of the tests have tried to address this by including pulse oximetry to measure a drop in 3 
oxygen saturation, however more recently this measure has been found not to be reliable in 4 
detecting aspiration(Wang, Chang, Chen, & Hsiao, 2005).  These tests are designed to identify 5 
dysphagia with aspiration being one aspect of that and silent aspirators may present with other signs 6 
of dysphagia (Ramsey, Smithard, & Kalra, 2005). This may limit the potential of any bedside test to 7 
attain high accuracy scores for identification of aspiration as to date there is no non-instrumental 8 
test that has been found to identify aspiration reliably.   9 
Both the VVST and the GUSS follow on from a preliminary screening component to identify those 10 
who may be at risk of aspiration or dysphagia.  The whole pathway (preliminary screen and test) has 11 
not been validated with consecutively admitted acute stroke patients for either of these tests. 12 
Perhaps this could be a more cost-effective pathway if both preliminary screening and then 13 
dysphagia testing are shown to be acceptable in diagnostic accuracy in methodologically robust 14 
studies.  15 
Heritage 2003 argues that to manage dysphagia effectively SLTs need to share their skills, 16 
responsibility and workload with nurses (Mary Heritage, 2003). Several publications suggested 17 
screening tests were not designed to replace the role of the SLT (23). Instead they were meant as 18 
easy-to-follow tools for those best placed (30) with the best skills (21) to identify patients with 19 
dysphagia so that SLT resources could be better directed to assessment and management of those 20 
most in need (20) .  The Interprofessional Dysphagia Framework (IDF) sets out how non-SLTs can 21 
develop skills in dysphagia assessment and management at different levels (E Boaden & Davies, 22 
2008).   The Foundation Level of training allows those competent, to carry out a protocol-guided 23 
swallowing assessment for which training and competency verification is required. The level of 24 
training required is set at a high standard because these tests involve making clinical judgements on 25 
signs of dysphagia and aspiration that may be subtle. In the UK, SLTs develop these skills by 26 
completing at least an undergraduate module and post graduate training in the theory of dysphagia 27 
and must accumulate 40 hours of clinical experience to be competent to practice (RCSLT, 2014). 28 
Training must therefore be essential if non-SLTs are assessing dysphagia. Whether training was 29 
required to use the tests identified in this review appeared variable and the DTNAx is the only tool 30 




This review only included studies published in in English or Spanish, therefore published and non-2 
published studies in other languages describing assessment tools may have been missed. There are 3 
likely to be many other nurse dysphagia assessments that have been developed by individual 4 
services that have not been published or described in the literature and therefore have not been 5 
included in this review. It is unlikely, however, that these in-house assessments have undergone 6 
rigorous validation without publication.   7 
Future directions 8 
To make decisions around which test is superior in diagnostic accuracy, further validation using 9 
robust study design is required. Information regarding clinical utility and cost effectiveness is also 10 
desirable to use with accuracy data to determine which tools should be used as standard in routine 11 
clinical practice. All the tests and gold standard comparators evaluate only small volumes of oral 12 
intake in order to make appropriate recommendations; however, little is known about how the 13 
recommendations are tolerated over time and whether there are any negative consequences such 14 
as pneumonia, choking incidents and malnutrition.  Further studies should consider comparing tools 15 
using clinical outcomes at later time-points to ensure the tools are safe and effective. Future hyper-16 
acute clinical trials may benefit from a robustly validated outcome tool that can be used by non-17 
specialists to identify dysphagia (Cohen et al., 2016).    18 
Conclusions  19 
There are several tools used by nurses and other non-specialists to screen for dysphagia and 20 
recommend oral intake for acute stroke patients with mild to moderate dysphagia.  Three have been 21 
validated and show that they are good at identifying patients at risk of aspiration and dysphagia, but 22 
often over diagnose, resulting in patients unnecessarily being kept NBM or on modified oral intake.  23 
Overall, however, the quality of studies in this review was graded as poor or showing low 24 
applicability for use by non-specialists to assess for dysphagia within the acute stroke setting. There 25 
is limited variable quality evidence that these tests may reduce pneumonia, reduce length of time 26 
patients are NBM and awaiting a swallowing assessment compared to no test. Further validation is 27 
required with robust study design to discover the accuracy, clinical utility and cost effectiveness of 28 
these tests so that they can be evaluated and compared.  29 
  30 
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Table 1. Summary of the multidisciplinary comprehensive swallowing assessment tools used in acute stroke  








Boaden 2011 Pre-screening & test with 
L0 and L4 consistencies. 
3 options: 
1. L0 fluids & L7 diet 
2. L4 diet and fluids 
3. NBM 






Heritage 2001, Heritage 
2003 & Benfield 2018 
Pre-screening checklist, 
Oromotor test, test of thin 
fluids progressing to level 2 
& 3 fluids if unsafe and test 
L4, L5, L6, L7 diet as safe. 
13 options: 
1. L0 fluids & L7 diet 
2. Any combination of L0, L2 or L3     
     fluids and L4, L5, L6, L7 diet 
3. NBM 
  
Nurses 20 minutes 1 day theory and practical. 
4 x assessments 
completed independently 




Trapl 2007, Ruiz Merino 
2014 (Ruiz Merino, 
Hochsprung, & Garcia 
Quesada, 2014), John 2015, 
AbdelHamid 2017, Samia 
2017, Palli 2017, Trapl 2017 
(Trapl, Firlinger, Teuschl, 
Dachenhausen, & Brainin, 
2017), Warneke 2017, 
Teuschl 2018, Ferreira 2018, 
Umay 2018 
Preliminary indirect 
assessment – cough & 
swallow function.  
Direct assessment with 3-5 
tsps (L3), 3, 5, 10, 20, 50 
mls L0, 1.5cm piece of L7 
diet x 5 
4 options 
1. L0 fluids & L7 diet  
2. Level 1-2 fluids and L5 or L6 diet 




5-10 minutes 10-15 minute theory, 
demonstration of GUSS by 




Rofes 2014, Clave 2008, 
Guillen-Sola 2013, Rofes 
2018 (Rofes et al., 2018) 
Assess 5, 10, 20 mls ~L2 
fluids, then 5, 10, 20mls 
thin fluids as safe, then 5, 
10 & 20mls L4 diet.  
Observation of signs & 
pulse oximetry. 
26 options:  
1. L0 fluids and L4 diet 
2. Any combination of 5, 10 or  
    20mls of L0 or ~L2 fluids and/or  






and SLTs.  




cases) and practice with 
real patients 
2 Volume, 3 
texture test 
(2v/3t-P) 
Cocho 2015 5mls then 10mls of ~L3/L4.  
5mls then 10mls of L0  
Then 1.5 cm piece L7 diet 
Observation of signs & 
pulse oximetry.  
Unclear but likely 6 options: 
1. 5 or 10mls L0 fluids & L7 diet 
2. Any combination of 5 or 10mls L0  
    and 5 or 10mls of L3/4 or L7 diet 
3. NBM 
Nurses No details No details 
International Dysphagia Diet Standardisation Initiative (IDDSI) Levels (L) are used. ~ is used to denote when the level is an estimation from another descriptor classification.  
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GUSS              
DTNAx              
BESST              
2v/3t-P              
VVST              
GUSS – Gugging Swallow Screen, DTNAx – Dysphagia Trained Nurse Assessment, BESST – Bedside Swallow Screening Test, 2v/3t-P – 2 Volume, 3 Texture 




Table 3. Diagnostic accuracy of multidisciplinary dysphagia assessments that have undergone validation.   





(and CI if 
reported) 
Specificity % 
(and CI if 
reported) 
PPV % 
(and CI if 
reported) 
NPV % 
(and CI if 
reported) 
ROC 











136 SLT bedside 
assessment 




From 70.1 (59.9 

















Clave 2008 85 VFS Aspiration 100  
 
28.8 28.8 100 Not reported Not assessed 
Guillen-Sola 
2013 
52 VFS Aspiration 88.2   
 
71.4 60 92.6 Not reported Not assessed 




21 94 Not reported k=0.628 
(0.45–0.78) 











50 FEES Aspiration 100 50-69 74-81 100 Group 1:  0.77 
(0.53 to 1.02) 
Group 2: 0.933 





42 FEES Aspiration  93.3 
 



































Samia 2017 40 FEES Aspiration 93.8 96.1 96.2 93.7 Not reported Not assessed 
Ferriera 
2018 
174 GUSS GUSS score 100 43 not reported 
– no data to 
calculate 
not reported 
– no data to 
calculate 
Nurse 1 = 0.987  
Nurse 2 = 0.991 





113 FEES Aspiration 
 
95.3-97.5 75.2-76.2 84.3 95.1-95.3 0.885-0.913 ICC = 0.955 
(0.935-0.969)  
p< 0.001 Dysphagia 
 
95.3-97.5 69.6-72.2 73.6-78.4 80.0-81.3 0.791– 0.822 
Dysphagia Trained Nurse Assessment (DTNAx)   Undergoing Validation – ClinicalTrials.gov Identifier: NCT03700853 
2 Volume,3 texture test (2v/3t-P)                                  No validation studies found 
CI =95% Confidence Interval, k= Kappa, kw = Weighted Kappa, ICC = Intra-class Correlation Coefficient, PPV = Positive predictive value, NPV = negative 
predictive value. ROC = Region under the Curve. The shaded areas indicated the studies that met the criteria for inclusion in meta-analysis. 
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Table 4. QUADAS-2 scores for risk of bias and concern for applicability of the diagnostic accuracy of the studies included in the systematic review 
multidisciplinary swallowing assessments.  
Assessment Study Patient selection  Index test Reference standard Flow and 
timing 
Overall quality of 
evidence based 

















Boden 2011 Low Low Low Low Low 
 







High High Low Unclear Low Low Unclear Very Low  **†‡¥ 
Guillen-Sola 
2013  
High High Unclear Unclear Unclear  Low High Very Low **‡%† 
Rofes 2014 
 




Trapl 2007  
 
High High Low Low Low Low Low Low **† 
Abdelhamed 
2015 
High High Low High Low Low Unclear Very low **‡¥† 
Warneke 2017  
 
High High Low High Low  Low Low Very low **‡†  
Samia 2017  
 
Unclear Unclear Unclear Unclear Unclear  Low Unclear Very low **‡¥†% 
Ferriera 2018 Unclear High Unclear Low High 
 
Low Unclear Very low **‡%¥† 
Umay 2018 
  
High High Unclear  Unclear Unclear Low Low Very low**‡% † 
Dysphagia Trained Nurse Assessment (DTNAx)   Undergoing Validation – ClinicalTrials.gov Identifier: NCT03700853 
 
2 Volume,3 texture test (2v/3t-P)                                  No validation studies found 
 
GRADE rating downgraded due to: %concern or uncertainty regarding risk of bias or applicability of reference test †imprecise results *concern or 
uncertainly regarding risk of bias or applicability of patient selection methods ‡concern or uncertainty regarding risk of bias and/or applicability of the index 
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